Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.38 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
| ▸ | BACE1 | P56817 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10324467 | 0.80 | BACE1 (0.46) | ALDH1A1MAPK1RAB9ANPC1HSD17B10 | |
| SCHEMBL17983434 | 0.78 | MAPT (0.46) | ALDH1A1MAPK1RAB9ANPC1HSD17B10 | |
| SCHEMBL9936678 | 0.78 | ALOX15 (0.42) | ALDH1A1MAPK1RAB9ACYP1A2LMNA | |
| SCHEMBL21248606 | 0.76 | MAPT (0.39) | ALDH1A1MAPK1HSD17B10LMNAMAPT | |
| SCHEMBL4855476 | 0.73 | ALDH1A1 (0.47) | ALDH1A1MAPK1RAB9ANPC1HSD17B10 | |
| SCHEMBL4580879 | 0.73 | ALDH1A1 (0.47) | ALDH1A1MAPK1RAB9ANPC1HSD17B10 | |
| Biphenyl SCHEMBL3277135 | 0.72 | ALDH1A1 (0.82) | ALDH1A1MAPK1RAB9ANPC1HSD17B10 | |
| Biphenyl SCHEMBL314415 | 0.72 | ALDH1A1 (0.82) | ALDH1A1MAPK1RAB9ANPC1HSD17B10 | |
| Biphenyl SCHEMBL1358618 | 0.71 | ALDH1A1 (1.00) | ALDH1A1MAPK1RAB9ANPC1HSD17B10 | |
| Biphenyl SCHEMBL4002609 | 0.71 | ALDH1A1 (1.00) | ALDH1A1MAPK1RAB9ANPC1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2423192-A1 | METAL COMPLEX HAVING AROMATIC LIGAND THAT CONTAINS NITROGEN ATOM | Sumitomo Chemical Company, Limited (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20120041203-A1 | METAL COMPLEX HAVING AROMATIC RING LIGAND CONTAINING NITROGEN ATOM | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-16 | — | — | US | disclosed |
| US-7771857-B2 | electrolyte membrane; phosphonic acid or sulfonic acid proton-conducting functional groups bound to aromatic polyarylene groups; hydrogen fuel cell; hydrolytic and oxidative stability; arylene resins from a sulfonated or phosphonated or carboxylated trifluoroacetophenone | GKSS-FORSCHUNGSZENTRUM GEESTHACHT GMBH (DE) | 2010-08-10 | — | — | US | disclosed |
| US-20090004528-A1 | PROTON-CONDUCTING POLYMER MEMBRANE | GKSS-FORSCHUNGSZENTRUM GEESTHACHT GMBH (DE) | 2009-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120041203-A1 | METAL COMPLEX HAVING AROMATIC RING LIGAND CONTAINING NITROGEN ATOM | MICA, CD4, CLTC | ALDH1A1 3458/4885MAPK1 3217/4885RAB9A 1532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.